CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,629 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02407197
NCT02407197N/ACompleted

International T1 Multicentre CMR Study

King's College London·observational·Posted Apr 2, 2015·Updated Mar 9, 2023

In Brief

An observational study for Cardiomyopathy and 5 related conditions. Completed, enrolled 1,629 participants across 4 sites in 3 countries.

Detailed Summary

Myocardial fibrosis is the fundamental substrate for the development of heart failure. Cardiovascular magnetic resonance (CMR) allows non-invasive assessment of myocardial fibrosis based on late gadolinium enhancement (LGE) and T1 mapping. Patients: Prospective longitudinal observational multicenter study of consecutive patients with suspected or known non-ischemic cardiomyopathy. Imaging: Non-invasive measures of myocardial fibrosis: native T1, extracellular volume fraction (ECV) and LGE. Primary endpoints: all cause and cardiovascular mortality. Secondary endpoints: arrhythmic composite and HF composite endpoints.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesAustralia, Germany, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2, 2015
Enrollment StartJan 1, 2011
Primary CompletionDec 1, 2017
Study CompletionDec 1, 2022
TodayJul 2, 2026
Enrollment to primary: 6.9 yearsPosted 11.3 years ago